Page last updated: 2024-11-05

trimebutine and Migraine Disorders

trimebutine has been researched along with Migraine Disorders in 2 studies

Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Trimebutine is an opioid derivative with exclusive action on receptors of the Meissner and Auerbach plexus throughout the digestive tube."2.72Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. ( Bigal, ME; Filho, PF; Krymchantowski, AV, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krymchantowski, AV1
Filho, PF1
Bigal, ME1
Tfelt-Hansen, P1
Olesen, J1

Trials

1 trial available for trimebutine and Migraine Disorders

ArticleYear
Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Drug Combinations; Female; Gastrointestinal Agents; Gastropa

2006

Other Studies

1 other study available for trimebutine and Migraine Disorders

ArticleYear
Increasing the effect of triptans in migraine.
    Lancet (London, England), 2006, Oct-14, Volume: 368, Issue:9544

    Topics: Cross-Over Studies; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Migraine Disorders;

2006